HK Stock Movement | SKB BIO-B (06990) Opens Over 5% Higher, Announces Clinical Research Results at ESMO 2025 Conference

Stock News
10/20

SKB BIO-B (06990) opened more than 5% higher, currently up 5.37% at HKD 483, with a trading volume of HKD 1.5939 million. The company announced that it presented several clinical research results at the 2025 European Society for Medical Oncology (ESMO) conference, being held in Berlin, Germany from October 17 to 21. The results include data on the anti-TROP2 antibody-drug conjugate sac-TMT (佳泰萊®), the anti-HER2 ADC A166 (舒泰萊®), and Claudin18.2 ADC SKB315.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10